Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
22 studies found for:    Open Studies | "Liver Cirrhosis, Biliary"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Liver Cirrhosis, Biliary"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
2 Recruiting Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Intervention: Genetic: Genetic Analysis
3 Recruiting Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Bezafibrate;   Drug: Ursodeoxycholic Acid;   Drug: Placebo (for Bezafibrate)
4 Recruiting The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Condition: Primary Biliary Cirrhosis
Intervention:
5 Recruiting Interrogating Potential Therapeutic Targets for Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Interventions: Other: Clinic visit;   Other: Baseline visit
6 Recruiting Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Dietary Supplement: S-adenosyl-L-methionine
7 Recruiting Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
8 Recruiting A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients
Condition: Primary Biliary Cirrhosis
Interventions: Drug: LJN452;   Drug: Placebo
9 Recruiting Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
10 Recruiting Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
11 Recruiting Pilot Study of FFP104 Dose Escalation in PBC Subjects
Condition: Primary Biliary Cirrhosis
Intervention: Drug: FFP104
12 Recruiting Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
13 Recruiting Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
14 Recruiting MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: MBX-8025 5 mg Capsule;   Drug: MBX-8025 10 mg Capsule;   Drug: MBX-8025 25 mg Capsule
15 Recruiting Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Condition: Primary Biliary Cirrhosis
Intervention:
16 Recruiting A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Condition: Biliary Cirrhosis, Primary
Intervention:
17 Recruiting sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis
Conditions: Primary Biliary Cirrhosis;   Liver Inflammation
Intervention: Other: Blood samples, fibroscan and questionaires
18 Recruiting sCD163 in PBC Patients - Assessment of Treatment Response
Conditions: Primary Biliary Cirrhosis;   Liver Inflammation;   Ursodeoxycholic Acid
Interventions: Other: Blood samples;   Device: Fibroscan;   Other: Questionnaires;   Biological: Liver biopsy
19 Not yet recruiting Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
Conditions: Hepatitis, Autoimmune;   Cholangitis;   Liver Cirrhosis, Biliary;   Cholestasis
Interventions: Drug: Ursodeoxycholic acid combination of immunosuppressive agents;   Drug: Ursodeoxycholic Acid
20 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.